# Appendix A — Key Definitions

Full definitions table with all 12 terms:
| Term | Definition |
|---|---|
| **ARR Run-Rate** | Annualized value of all active subscriptions at quarter end. $125k contract in Week 10 = $125k ARR (not prorated) |
| **Qualified Opportunity** | Deal at S2+ with confirmed pain, champion, process, and budget discussion |
| **BRA Pipeline** | The three-step process: Step 1 "Context" → Step 2 "Benefit & Risk Assessment" → Step 3 "Data Analysis" |
| **Therapeutic Axis / Disease-Specific Version** | A structured dataset (Landscape, Disease, Benefit, Risk) for a specific disease area, validated and integrated into the platform with a functional demo |
| **Definition of Done (O1)** | Data Quality Validation + Data Traceability + Platform Usage Analysis + Platform Perf Monitoring + Code Quality Gate + 80% Code Tested — all six criteria |
| **Definition of Done (O2 — per Axis)** | Dataset Structured (KR2.1) + External Validation + Internal Validation + LLM Validation (KR2.2) + Integrated in Platform + Demo Ready (KR2.3) |
| **F1 Score** | Harmonic mean of precision and recall — used to measure accuracy of endpoint extraction pipelines |
| **Pipeline Coverage** | Qualified pipeline $ / remaining ARR target. Minimum 3x |
| **BRAT** | Benefit-Risk Action Team framework (regulatory standard) |
| **CIOMS** | Council for International Organizations of Medical Sciences |
| **APM** | Application Performance Monitoring — tracks user actions, errors, treatment time, cost |
| **SonarQube Quality Gate** | Automated code quality check that all Prod deployments must pass |

*Extracted from ArcaScience OKR Execution Blueprint — Appendix*
